You are here

  • Home
  • Archive
  • Volume 4, Issue 3
  • Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial

Article metrics

Article menu

Download PDFPDF

Original article
Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial

 

Online download statistics by month:

Online download statistics by month: April 2019 to March 2024

AbstractFullPdf
Apr 201913012838
May 201919317355
Jun 201913513317
Jul 201911611512
Aug 2019404016
Sep 2019828119
Oct 2019949134
Nov 2019949442
Dec 2019868138
Jan 2020575537
Feb 2020545026
Mar 2020464632
Apr 202031299
May 2020363611
Jun 2020484621
Jul 2020545522
Aug 2020595735
Sep 2020524522
Oct 2020444115
Nov 2020696539
Dec 2020635429
Jan 2021706757
Feb 2021958375
Mar 2021928949
Apr 2021594843
May 2021797944
Jun 2021585641
Jul 2021555229
Aug 2021686650
Sep 2021444027
Oct 2021938765
Nov 2021938953
Dec 2021706839
Jan 202221521647
Feb 2022808049
Mar 2022848674
Apr 2022837843
May 2022736943
Jun 2022767943
Jul 2022615530
Aug 2022868354
Sep 2022676537
Oct 202210310060
Nov 202210310158
Dec 2022726932
Jan 2023363429
Feb 20231059846
Mar 2023948951
Apr 2023798248
May 2023776649
Jun 2023595530
Jul 2023888251
Aug 2023988942
Sep 202311911334
Oct 202318117647
Nov 202331230946
Dec 202314912668
Jan 202411010457
Feb 202418211461
Mar 2024236223186
Total548751802556